Demonstration of conjugative transposon (Tn5397)-mediated horizontal gene transfer between Clostridium difficile and Enterococcus faecalis

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 11, 2010, Pages 4924-4926

  Jasni, Azmiza S ^a   Mullany, Peter ^a   Hussain, Haitham ^a   Roberts, Adam P ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIUM CONJUGATION; CLOSTRIDIUM DIFFICILE; ENTEROCOCCUS FAECALIS; HORIZONTAL GENE TRANSFER; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TRANSPOSON;

CLOSTRIDIUM DIFFICILE; DNA TRANSPOSABLE ELEMENTS; ENTEROCOCCUS FAECALIS; GENE TRANSFER, HORIZONTAL;

EID: 78049292276     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00496-10     Document Type: Article

References (25)

1. Al-Nassir, W. N., A. K. Sethi, Y. Li, M. J. Pultz, M. M. Riggs, and C. J. Donskey. 2008. Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile-associated disease. Antimicrob. Agents Chemother. 52: 2403-2406.
2. Amyes, S. G. B. 2007. Enterococci and streptococci. Int. J. Antimicrob. Agents 29:43-52.
3. Arias, C. A., G. A. Contreras, and B. E. Murray. 2010. Management of multi-drug resistant enterococcal infections. Clin. Infect. Dis. 16:556-562.
4. Baines, S. D., R. O'Connor, K. Saxton, J. Freeman, and M. H. Wilcox. 2009. Activity of vancomycin against epidemic Clostridium difficile strains in a human gut model. J. Antimicrob. Chemother. 663:520-525.
5. Donskey, C. J., A. J. Ray, C. K. Hoyen, P. D. Fuldauer, D. C. Aron, and R. A. Bonomo. 2003. Cocolonization and infection with multiple nosocomial pathogens in patients colonized with vancomycin-resistant enterococci. Infect. Control Hosp. Epidemiol. 24:242-245.
6. Garnier, F., S. Taourit, P. Glaser, P. Courvalin, and M. Galimand. 2000. Characterization of transposon Tn1549, comferring VanB-type resistance in Enterococcus spp. Microbiology 146:1481-1489.
7. Gerding, D. N. 1997. Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection? Clin. Infect. Dis. 25(Suppl. 2):S206-S210.
8. Gerding, D. N., S. Johnson, L. R. Peterson, M. E. Mulligan, and J. Silva, Jr. 1995. Clostridium difficile-associated diarrhea and colitis. Infect. Control Hosp. Epidemiol. 16:459-477.
9. Healthcare Commission. 2006. Investigation into outbreaks of Clostridium difficile at Stoke Mandeville Hospital, Buckinghamshire Hospitals NHS Trust. Healthcare Commission, London, United Kingdom. http://www.cqc.org.uk/-db/- documents/Stoke-Mandeville.pdf.
10. Huang, H., A. Weintraub, H. Fang, and C. E. Nord. 2009. Antimicrobial resistance in Clostridium difficile. Int. J. Antimicrob. Agents 34:516-522.
11. Jacob, A. E., and S. J. Hobbs. 1974. Conjugal transfer of plasmid-borne multiple antibiotic resistance in Streptococcus faecalis var. zymogenes. J. Bacteriol. 117:360-372.
12. Leclercq, R. 2009. Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococci. Clin. Microbiol. Infect. 15:224-231.
13. Leffler, D. A., and J. T. Lamont. 2009. Treatment of Clostridium difficile-associated disease. Gastroenterology 136:1899-1912.
14. Mullany, P., M. Wilks, L. Lamb, C. Clayton, B. Wren, and S. Tabaqchali. 1990. Genetic analysis of a tetracycline resistance element from Clostridium difficile and its conjugal transfer to and from Bacillus subtilis. J. Gen. Microbiol. 136:1343-1349.
15. Pepin, J. 2008. Vancomycin for the treatment of Clostridium difficile infection: for whom is this expensive bullet really magic? Clin. Infect. Dis. 46: 1493-1498.
16. Roberts, A. P., and P. Mullany. 2009. A modular master on the move: the Tn916 family of mobile genetic elements. Trends Microbiol. 17:251-258.
17. Roberts, A. P., M. Chandler, P. Courvalin, G. Guédon, P. Mullany, T. Pembroke, J. I. Rood, C. J. Smith, A. O. Summers, M. Tsuda, and D. E. Berg. 2008. Revised nomenclature for transposable genetic elements. Plasmid 60: 167-173.
18. Roberts, A. P., P. Mullany, and M. Wilson. 2001. Gene transfer in bacterial biofilms. Methods Enzymol. 336:60-65.
19. Rupnik, M., M. H. Wilcox, and D. N. Gerding. 2009. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat. Rev. Microbiol. 7:526-536.
20. Tsvetkova, K., J.-C. Marvaud, and T. Lambert. 2010. Analysis of the mobilization functions of the vancomycin resistance transposon Tn1549, a member of a new family of conjugative elements. J. Bacteriol. 192:702-713.
21. Wang, H., A. P. Roberts, D. Lyras, J. I. Rood, M. Wilks, and P. Mullany. 2000. Characterization of the ends and target sites of the novel conjugative transposon Tn5397 from Clostridium difficile: excision and circularization is mediated by the large resolvase, TndX. J. Bacteriol. 182:3775-3783.
22. Wang, H., and P. Mullany. 2000. The large resolvase TndX is required and sufficient for integration and excision of derivatives of the novel conjugative transposon Tn5397. J. Bacteriol. 182:6577-6583.
23. Wang, H., M. C. M. Smith, and P. Mullany. 2006. The conjugative transposon Tn5397 has a strong preference for integration into its Clostridium difficile target site. J. Bacteriol. 188:4871-4878.
24. Woodford, N., and D. M. Livermore. 2009. Infections caused by Grampositive bacteria: a review of the global challenge. J. Infect. 59(Suppl. 1): S4-S16.
25. Wüst, J. N., and U. Hardegger. 1983. Transferable resistance to clindamycin, erythromycin and tetracycline in Clostridium difficile. Antimicrob. Agents Chemother. 23:784-786.